Product category:
Laboratory and scientific exhibitions and conferences
News Release from: Select Biosciences | Subject: Oncoproteomics congress
Edited by the Laboratorytalk Editorial
Team on 21 October 2005
Congress tackles oncoproteomics
The first World Oncoproteomics Congress is to be held in south San Francisco on 27-28 April 2006 to discuss biomarkers, molecular diagnostics, and personalised therapies for cancer
Select Conferences announces the inaugural world congress dedicated to oncoproteomics This field has developed rapidly over recent years and now is a good time to assess its success to date together with future opportunities and challenges
This article was originally published on Laboratorytalk on 7 May 2003 at 8.00am (UK)
Related stories
Protein biochip market remains wide open
Market report is based on extensive primary and secondary research, including interviews with current and potential customers and interviews with company representatives
The agenda will include cancer biomarkers, molecular diagnostics for cancer, laser capture microdissection, protein biochips, changes in proteome in cancer, and personalised therapies for cancer.
Some world class keynote speakers already confirmed with more pending.
To date they include Jack Roth, University of Texas Anderson Cancer Center, Gordon Whiteley, director, Clinical Proteomics Reference Lab, KK Jain, president, Jain PharmaBiotech.
Select Conferences is a division of Select Biosciences, focused on organising specialist biomedical meetings.
Experts from both academia and commerce are invited to present timely information from current research through to commercial implementation of new technologies.
These events also provide a unique networking facility and the opportunity to reach a highly targeted scientific audience.
• Select Biosciences: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
